Cel-Sci Corporation

3.89-0.2400-5.81%Vol 217.57K1Y Perf -54.57%
Aug 9th, 2022 16:00 DELAYED
BID3.87 ASK3.96
Open4.08 Previous Close4.13
Pre-Market- After-Market3.89
 - -  - -%
Target Price
13.00 
Analyst Rating
Strong Buy 1.00
Potential %
234.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
13.45 
Earnings Rating
Sell
Market Cap168.55M 
Earnings Date
15th Aug 2022
Alpha0.06 Standard Deviation0.43
Beta1.92 

Today's Price Range

3.884.26

52W Range

2.4912.90

5 Year PE Ratio Range

-8.70-2.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
4.29%
1 Month
-15.80%
3 Months
33.68%
6 Months
-30.66%
1 Year
-54.57%
3 Years
-52.27%
5 Years
75.23%
10 Years
-95.42%

TickerPriceChg.Chg.%
CVM3.89-0.2400-5.81
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.16-0.23-43.75
Q01 2022--0.20-
Q04 2021-0.10-0.19-90.00
Q03 2021-0.13-0.25-92.31
Q02 2021-0.19-0.20-5.26
Q01 2021--0.21-
Q04 2020--0.14-
Q03 2020-0.15-0.27-80.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.150.00-
9/2022 QR-0.130.00-
9/2022 FY-0.54-10.20Negative
9/2023 FY0.27-70.33Negative
Next Report Date15th Aug 2022
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume217.57K
Shares Outstanding43.33K
Shares Float41.64M
Trades Count2.09K
Dollar Volume869.39K
Avg. Volume406.47K
Avg. Weekly Volume256.54K
Avg. Monthly Volume329.10K
Avg. Quarterly Volume633.78K

Cel-Sci Corporation (AMEX: CVM) stock closed at 3.89 per share at the end of the most recent trading day (a -5.81% change compared to the prior day closing price) with a volume of 217.57K shares and market capitalization of 168.55M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Cel-Sci Corporation CEO is Geert R. Kersten.

The one-year performance of Cel-Sci Corporation stock is -54.57%, while year-to-date (YTD) performance is -45.21%. CVM stock has a five-year performance of 75.23%. Its 52-week range is between 2.49 and 12.9, which gives CVM stock a 52-week price range ratio of 13.45%

Cel-Sci Corporation currently has a PE ratio of -4.40, a price-to-book (PB) ratio of 3.69, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -65.58%, a ROC of -67.15% and a ROE of -98.91%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cel-Sci Corporation, there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Cel-Sci Corporation’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for Cel-Sci Corporation is Strong Buy (1), with a target price of $13, which is +234.19% compared to the current price. The earnings rating for Cel-Sci Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cel-Sci Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cel-Sci Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 24.98, ATR14 : 0.34, CCI20 : 25.98, Chaikin Money Flow : -0.13, MACD : -0.02, Money Flow Index : 49.21, ROC : 1.83, RSI : 43.46, STOCH (14,3) : 42.25, STOCH RSI : 0.58, UO : 48.60, Williams %R : -57.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cel-Sci Corporation in the last 12-months were: Eyal Talor (Sold 15 000 shares of value $168 750 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEO: Geert R. Kersten

Telephone: +1 703 506-9460

Address: 8229 Boone Boulevard, Vienna 22182, VA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

57%43%


News

Stocktwits